Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Adalimumab Extension in Japanese RA Patients
NCT00235833Phase 2Completed
- Sponsor
- Abbott Laboratories
- Start
- Jun 2003
- Primary completion
- Oct 2004
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of adalimumab in rheumatoid arthritis (RA), sponsored by Abbott Laboratories. Started Jun 2003; status: completed.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00235833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00235833.